Trials / Unknown
UnknownNCT04664985
Evaluation of Mucogyne® Ovule in Vulvovaginal Dryness Management in Women Treated by Brachytherapy and/or Radiotherapy for Endometrial or Cervical Cancer.
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 80 (estimated)
- Sponsor
- Laboratoires IPRAD · Industry
- Sex
- Female
- Age
- 18 Years – 99 Years
- Healthy volunteers
- Not accepted
Summary
Randomized, open-label, national (France), multicenter, prospective clinical study, to evaluate the superiority of Mucogyne® ovules over the control group on vaginal health (including hydration) in women treated by brachytherapy and/or radiotherapy for endometrial or cervical cancer.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Mucogyne® ovule | hyaluronic acid, vaginal ovule |
Timeline
- Start date
- 2020-10-06
- Primary completion
- 2022-08-31
- Completion
- 2023-01-31
- First posted
- 2020-12-11
- Last updated
- 2022-01-03
Locations
7 sites across 1 country: France
Source: ClinicalTrials.gov record NCT04664985. Inclusion in this directory is not an endorsement.